Advisory committee recommended it be approved as a preventive . The FDA does not have to follow the recommendations of its advisory committees . The FDA looked at safety and efficacy data from the clinical trials .
Advisory committee recommends Truvan be approved as a preventive . The FDA does not have to follow the recommendations of its advisory committees . The panel looked at safety and efficacy data from 3 clinical trials .